MapLight Therapeutics, Inc. Common Stock (MPLT)
Healthcare
Biotechnology
—
13.00 $
-7.2%
vs. previous close
Closing price · As of: 31. Jul 2026
MapLight Therapeutics, Inc. Common Stock (MPLT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -51 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q1 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -20 | -18 | -20 | -21 | -26 | -34 | -32 | -47 | -51 | -164 | |
| 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.6 | |
| – | – | – | 0.4 | 0.2 | – | – | 0.1 | 36 | 9.6 | – | |
| -0.5 | -2.1 | 0.2 | -0.7 | -0.5 | -3.5 | -5.2 | -2.4 | -1.7 | 0.3 | -9.0 | |
| 0.1 | 0.0 | 0.3 | 0.4 | 0.1 | 0.0 | 0.1 | 0.0 | 0.4 | 0.0 | 0.5 | |
| -0.1 | 0.0 | -122 | 8.6 | 32 | 38 | 17 | -136 | -243 | 67 | -294 | |
| 0.0 | 120 | -1.7 | -0.2 | 0.0 | 0.0 | -0.2 | 198 | 272 | -6.9 | 463 | |
| 16 | 180 | -180 | -11 | 11 | 50 | -17 | 31 | -17 | 9.0 | 5.6 | |
| -12 | -20 | -18 | -20 | -22 | -26 | -34 | -32 | -47 | -51 | -164 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.